Показано 0 из 0
Дата |
---|
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
18.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
3.52
|
4.25
|
3.53
|
3.53
|
3.53
|
3.53
|
|
|
394.34
|
3.00
|
3.33
|
3.50
|
3.65
|
3.50
|
3.68
|
3.50
|
|
|
21 303.15
|
19.00
|
3.60
|
4.25
|
4.20
|
3.60
|
4.26
|
3.60
|
|
|
43 946.00
|
52.00
|
4.07
|
4.40
|
3.62
|
3.42
|
4.10
|
4.07
|
|
|
36 377.76
|
45.00
|
|
|
3.76
|
3.51
|
3.89
|
3.62
|
|
|
21 692.08
|
31.00
|
3.76
|
4.40
|
3.90
|
3.90
|
3.98
|
3.95
|
|
|
31 592.20
|
24.00
|
3.90
|
4.45
|
3.95
|
3.95
|
3.95
|
3.95
|
|
|
6 715.00
|
4.00
|
3.77
|
4.45
|
4.00
|
4.00
|
4.17
|
4.07
|
|
|
22 260.00
|
31.00
|
4.06
|
4.65
|
4.07
|
4.00
|
4.07
|
4.07
|
|
|
16 118.00
|
9.00
|
3.82
|
4.65
|
4.16
|
4.10
|
4.24
|
4.24
|
|
|
7 852.00
|
14.00
|
XORTX Therapeutics Inc (XORTX) is a drug development company primarily focused on orphan disease indications which have a uric acid imbalance as well as metabolic syndrome, diabetes and diabetic nephropathy